Nuzenio

Reckitt

Reckitt news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 19 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 17:06:25 GMTFDA approves Reckitt’s new Mucinex cold, flu medicine - NJBIZ
Fri, 07 Aug 2026 16:07:00 GMTReckitt Benckiser Group rises Friday, outperforms market - MarketWatch
Fri, 07 Aug 2026 05:34:28 GMTReckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk - Seeking Alpha
Wed, 05 Aug 2026 13:09:07 GMTReckitt announces U.S. FDA approval of Mucinex 12HR Cold & Fever Multi-Symptom, the first OTC innovation in the cold & flu category in 14 years - reckitt.com
Wed, 05 Aug 2026 11:17:44 GMTReckitt kicks off £150M first tranche of £500M buyback with Citi - Dealroom
Wed, 05 Aug 2026 10:08:45 GMTReckitt Benckiser Group (LON:RKT) Given New GBX 5,352 Price Target at Berenberg Bank - MarketBeat

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Reckitt.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

19 distinct publisher/source names are currently connected to this entity page.